Delivery Order SPE2DB24D2205-SPE2DB25FEENT
- Not listed
- This is a $13,846.97 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, with a period of performance through July 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $13,846.97 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, with a period of performance ending on July 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,846.97 contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a completion date of July 22, 2025. The contract is not set aside and is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a ceiling value of $13,846.97 and a period of performance through May 13, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a ceiling value of $13,846.97 and a performance period through May 9, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
- This is a $13,846.97 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, with a performance period ending on July 24, 2025. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYNDAMAX 61 MG CAPSULE UD 30S. The contract has a ceiling value of $13,846.97 and a period of performance through June 17, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, with a ceiling value of $27,693.94 and a period of performance ending on July 25, 2025. The contract is not set aside. Amerisourcebergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $13,846.97, and a period of performance through July 2, 2025. This contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,846.97, is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 9, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEENTDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with an ultimate completion date of July 28, 2025 and a ceiling value of $13,846.97. The contract is not designated as a set-aside. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This prime contract enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 7/7/25 |